Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brewer

Showing results (521-530 of 533) with videos related to

Pageof 54
Sort By:
Blood|May 20, 2009
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLaura A Johnson, Richard A Morgan, Mark E Dudley, et al.
Journal of the American College of Cardiology|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
Circulation|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Roger S Blumenthal, Pamela B Morris, et al.
Circulation|June 22, 2026
Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
JAMA|March 18, 2024
Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsLeighton Chan, Mark Hallett, Chris K Zalewski, et al.
JAMA|March 18, 2024
Neuroimaging Findings in US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsCarlo Pierpaoli, Amritha Nayak, Rakibul Hafiz, et al.
Genetics in Medicine Open|July 15, 2025
Systematic phenotype and genotype characterization of Moebius syndromeBryn D Webb, Julie A Jurgens, Narisu Narisu, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Nature Genetics|June 29, 2023
Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresisAlan P Tenney, Silvio Alessandro Di Gioia, Bryn D Webb, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 54

Showing results (521-530 of 533) with videos related to

Sort By:
Pageof 54
Blood|May 20, 2009
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLaura A Johnson, Richard A Morgan, Mark E Dudley, et al.
Journal of the American College of Cardiology|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
Circulation|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Roger S Blumenthal, Pamela B Morris, et al.
Circulation|June 22, 2026
Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
JAMA|March 18, 2024
Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsLeighton Chan, Mark Hallett, Chris K Zalewski, et al.
JAMA|March 18, 2024
Neuroimaging Findings in US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsCarlo Pierpaoli, Amritha Nayak, Rakibul Hafiz, et al.
Genetics in Medicine Open|July 15, 2025
Systematic phenotype and genotype characterization of Moebius syndromeBryn D Webb, Julie A Jurgens, Narisu Narisu, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Nature Genetics|June 29, 2023
Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresisAlan P Tenney, Silvio Alessandro Di Gioia, Bryn D Webb, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 54